Whole-body magnetic resonance angiography with additional steady-state acquisition of the infragenicular arteries in patients with peripheral arterial disease

CardioVascular and Interventional Radiology

Volumn 33, Issue 3, 2010, Pages 484-491

  Nielsen, Yousef W ^a   Eiberg, Jonas P ^b   Løgager, Vibeke B ^a   Just, Sven ^c   Schroeder, Torben V ^b   Thomsen, Henrik S ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b Rigshospitalet   (Denmark)

^c Mental Health Services CPH   (Denmark)

Author keywords

Digital subtraction angiography; Magnetic resonance angiography; Peripheral arterial disease; Steady state; Whole body

Indexed keywords

GADOFOSVESET;

ADULT; AGED; ARTERY DISEASE; ARTERY OCCLUSION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIGITAL SUBTRACTION ANGIOGRAPHY; FEMALE; FIRST PASS EFFECT; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; INTERMETHOD COMPARISON; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; STEADY STATE; WHOLE BODY IMAGING;

AGED; ANGIOGRAPHY, DIGITAL SUBTRACTION; CONTRAST MEDIA; FEMALE; GADOLINIUM; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; IOPAMIDOL; LEG; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; PERIPHERAL VASCULAR DISEASES; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; WHOLE BODY IMAGING;

EID: 77953132370     PISSN: 01741551     EISSN: 1432086X     Source Type: Journal    
DOI: 10.1007/s00270-009-9759-4     Document Type: Article

References (33)

1. Collins R, Burch J, Cranny G et al (2007) Duplex ultrasonography, magnetic resonance angiography, and computed tomography angiography for diagnosis and assessment of symptomatic, lower limb peripheral arterial disease: systematic review. Br Med J 334:1257-1266
2. Koelemay MJ, Lijmer JG, Stoker J et al (2001) Magnetic resonance angiography for the evaluation of lower extremity arterial disease: a meta-analysis. JAMA 285:1338-1345
3. Goyen M, Quick HH, Debatin JF et al (2002) Whole-body threedimensional MR angiography with a rolling table platform: initial clinical experience. Radiology 224:270-277
4. Hansen T, Wikstrom J, Eriksson MO et al (2006) Whole-body magnetic resonance angiography of patients using a standard clinical scanner. Eur Radiol 16:147-153
5. Ruehm SG, Goyen M, Barkhausen J et al (2001) Rapid magnetic resonance angiography for detection of atherosclerosis. Lancet 357(9262):1086-1091
6. Ruehm SG, Goehde SC, Goyen M (2004) Whole body MR angiography screening. Int J Cardiovasc Imaging 20:587-591
7. Lauffer RB, Parmelee DJ, Dunham SU et al (1998) MS-325: albumin-targeted contrast agent for MR angiography. Radiology 207:529-538
8. Goyen M (2008) Gadofosveset-enhanced magnetic resonance angiography. Vasc Health Risk Manag 4:1-9
9. Grist TM, Korosec FR, Peters DC et al (1998) Steady-state and dynamic MR angiography with MS-325: initial experience in humans. Radiology 207:539-544
10. Hadizadeh DR, Gieseke J, Lohmaier SH et al (2008) Peripheral MR angiography with blood pool contrast agent: prospective intraindividual comparative study of high-spatial-resolution steady-state MR angiography versus standard-resolution first-pass MR Angiography and DSA. Radiology 249:701-711
11. Michaely HJ, Attenberger UI, Dietrich O et al (2008) Feasibility of gadofosveset-enhanced steady-state magnetic resonance angiography of the peripheral vessels at 3 Tesla with Dixon fat saturation. Invest Radiol 43:635-641
12. Levey AS, Bosch JP, Lewis JB et al (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 30:461-470
13. Nielsen YW, Eiberg JP, Logager VB et al (2009) Whole-body MR angiography with body coil acquisition at 3 T in patients with peripheral arterial disease using the contrast agent gadofosveset trisodium. Acad Radiol 16:654-661
14. Fenchel M, Requardt M, Tomaschko K et al (2005) Whole-body MR angiography using a novel 32-receiving-channel MR system with surface coil technology: first clinical experience. J Magn Reson Imaging 21:596-603
15. Goyen M, Herborn CU, Kroger K et al (2003) Detection of atherosclerosis: systemic imaging for systemic disease with whole-body three-dimensional MR angiography-initial experience. Radiology 227:277-282
16. Herborn CU, Goyen M, Quick HH et al (2004) Whole-body 3D MR angiography of patients with peripheral arterial occlusive disease. AJR Am J Roentgenol 182:1427-1434
17. Hartmann M, Wiethoff AJ, Hentrich HR et al (2006) Initial imaging recommendations for Vasovist angiography. Eur Radiol 16(Suppl 2):B15-B23
18. Rohrer M, Bauer H, Mintorovitch J et al (2005) Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Invest Radiol 40:715-724
19. Hoogeveen RM, Bakker CJ, Viergever MA (1998) Limits to the accuracy of vessel diameter measurement in MR angiography. J Magn Reson Imaging 8:1228-1235
20. Maki JH, Wilson GJ, Eubank WB et al (2002) Utilizing SENSE to achieve lower station sub-millimeter isotropic resolution and minimal venous enhancement in peripheral MR angiography. J Magn Reson Imaging 15:484-491
21. Alexandrova NA, Gibson WC, Norris JW et al (1996) Carotid artery stenosis in peripheral vascular disease. J Vasc Surg 23:645-649
22. Drouet L (2002) Atherothrombosis as a systemic disease. Cerebrovasc Dis 13 (Suppl 1):1-6
23. Wachtell K, Ibsen H, Olsen MH et al (1996) Prevalence of renal artery stenosis in patients with peripheral vascular disease and hypertension. J Hum Hypertens 10:83-85
24. Goyen M, Herborn CU, Kroger K et al (2006) Total-body 3D magnetic resonance angiography influences the management of patients with peripheral arterial occlusive disease. Eur Radiol 16:685-691
25. Goehde SC, Hunold P, Vogt FM et al (2005) Full-body cardiovascular and tumor MRI for early detection of disease: feasibility and initial experience in 298 subjects. AJR Am J Roentgenol 184:598-611
26. Hansen T, Ahlstrom H, Johansson L (2007) Whole-body screening of atherosclerosis with magnetic resonance angiography. Top Magn Reson Imaging 18:329-337
27. Hansen T, Ahlstrom H, Wikstrom J et al (2008) A total atherosclerotic score for whole-body MRA and its relation to traditional cardiovascular risk factors. Eur Radiol 18:1174-1180
28. Ladd SC, Debatin JF, Stang A et al (2007) Whole-body MR vascular screening detects unsuspected concomitant vascular disease in coronary heart disease patients. Eur Radiol 17:1035-1045
29. de Vries M, Nijenhuis RJ, Hoogeveen RM et al (2005) Contrastenhanced peripheral MR angiography using SENSE in multiple stations: feasibility study. J Magn Reson Imaging 21:37-45
30. Fenchel M, Doering J, Seeger A et al (2008) Ultrafast wholebody MR angiography with two-dimensional parallel imaging at 3.0 T: feasibility study. Radiology 250:254-263
31. Klessen C, Hein PA, Huppertz A et al (2007) First-pass wholebody magnetic resonance angiography (MRA) using the bloodpool contrast medium gadofosveset trisodium: comparison to gadopentetate dimeglumine. Invest Radiol 42:659-664
32. Nael K, Ruehm SG, Michaely HJ et al (2007) Multistation wholebody high-spatial-resolution MR angiography using a 32-channel MR system. AJR Am J Roentgenol 188:529-539
33. Nael K, Krishnam M, Nael A et al (2008) Peripheral contrastenhanced MR angiography at 3.0T, improved spatial resolution and low dose contrast: initial clinical experience. Eur Radiol 18:2893-2900